GDF7
Basic information
Region (hg38): 2:20667144-20679243
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the GDF7 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 26 | 30 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 26 | 2 | 3 |
Variants in GDF7
This is a list of pathogenic ClinVar variants found in the GDF7 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
2-20667261-G-A | not specified | Uncertain significance (Dec 15, 2022) | ||
2-20667363-G-A | not specified | Uncertain significance (Dec 22, 2023) | ||
2-20667415-C-T | not specified | Uncertain significance (Dec 03, 2024) | ||
2-20667432-G-A | not specified | Uncertain significance (Sep 29, 2022) | ||
2-20667445-G-A | not specified | Uncertain significance (Sep 23, 2023) | ||
2-20667472-G-T | not specified | Uncertain significance (Sep 14, 2023) | ||
2-20667483-A-T | not specified | Uncertain significance (Jun 10, 2024) | ||
2-20667508-A-G | not specified | Uncertain significance (Jul 17, 2024) | ||
2-20667543-A-G | Likely benign (Apr 01, 2023) | |||
2-20667577-C-G | not specified | Uncertain significance (Sep 25, 2024) | ||
2-20667621-G-A | not specified | Uncertain significance (Jan 16, 2024) | ||
2-20667622-C-A | not specified | Uncertain significance (Nov 25, 2024) | ||
2-20670581-G-A | not specified | Uncertain significance (Jul 30, 2024) | ||
2-20670583-C-T | not specified | Uncertain significance (Jul 09, 2021) | ||
2-20670649-C-G | not specified | Uncertain significance (Jun 16, 2024) | ||
2-20670659-A-C | not specified | Uncertain significance (Oct 26, 2022) | ||
2-20670715-G-A | not specified | Uncertain significance (Oct 12, 2021) | ||
2-20670721-A-G | not specified | Likely benign (Aug 04, 2023) | ||
2-20670727-C-T | not specified | Uncertain significance (May 08, 2024) | ||
2-20670752-C-G | not specified | Uncertain significance (Jan 29, 2024) | ||
2-20670791-C-G | not specified | Uncertain significance (May 08, 2023) | ||
2-20670815-G-A | not specified | Uncertain significance (Jun 27, 2023) | ||
2-20670851-C-T | not specified | Uncertain significance (Aug 10, 2021) | ||
2-20670862-G-C | not specified | Uncertain significance (Jan 18, 2022) | ||
2-20670868-G-A | not specified | Uncertain significance (Oct 05, 2021) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
GDF7 | protein_coding | protein_coding | ENST00000272224 | 2 | 6995 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.631 | 0.363 | 124024 | 0 | 2 | 124026 | 0.00000806 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 1.80 | 135 | 208 | 0.648 | 0.0000131 | 2728 |
Missense in Polyphen | 69 | 116.82 | 0.59066 | 1239 | ||
Synonymous | 1.66 | 79 | 100 | 0.789 | 0.00000695 | 1043 |
Loss of Function | 2.19 | 1 | 7.44 | 0.134 | 3.59e-7 | 96 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.00 | 0.00 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.00000903 | 0.00000903 |
Middle Eastern | 0.00 | 0.00 |
South Asian | 0.00 | 0.00 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: May play an active role in the motor area of the primate neocortex. {ECO:0000250}.;
- Pathway
- TGF-beta signaling pathway - Homo sapiens (human);Axon guidance - Homo sapiens (human);Hippo signaling pathway - Homo sapiens (human);GPCR signaling-G alpha q;GPCR signaling-cholera toxin;GPCR signaling-pertussis toxin;TGF-beta super family signaling pathway canonical;GPCR signaling-G alpha s Epac and ERK;GPCR signaling-G alpha s PKA and ERK;GPCR signaling-G alpha i;BMP2 signaling TGF-beta MV;BMP signaling Dro
(Consensus)
Recessive Scores
- pRec
- 0.103
Haploinsufficiency Scores
- pHI
- 0.0791
- hipred
- N
- hipred_score
- 0.464
- ghis
- 0.428
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.298
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Gdf7
- Phenotype
- endocrine/exocrine gland phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); reproductive system phenotype; nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- axon guidance;regulation of signaling receptor activity;positive regulation of pathway-restricted SMAD protein phosphorylation;roof plate formation;spinal cord association neuron differentiation;gland morphogenesis;BMP signaling pathway;epithelial cell differentiation;midbrain development;activin receptor signaling pathway;regulation of apoptotic process;regulation of MAPK cascade;cell fate commitment;positive regulation of neuron differentiation;positive regulation of transcription, DNA-templated;cell development;reproductive structure development;branching morphogenesis of an epithelial tube;forebrain morphogenesis;pathway-restricted SMAD protein phosphorylation;SMAD protein signal transduction;morphogenesis of an epithelial fold;positive regulation of tendon cell differentiation
- Cellular component
- extracellular space
- Molecular function
- cytokine activity;transforming growth factor beta receptor binding;protein binding;growth factor activity;protein homodimerization activity